T-CELLS MADE DEFICIENT IN INTERLEUKIN-2 PRODUCTION BY EXPOSURE TO STAPHYLOCOCCAL-ENTEROTOXIN-B IN-VIVO ARE PRIMED FOR INTERFERON-GAMMA AND INTERLEUKIN-10 SECRETION

被引:52
作者
FLORQUIN, S
AMRAOUI, Z
GOLDMAN, M
机构
[1] FREE UNIV BRUSSELS,HOP ERASME,DEPT IMMUNOL,B-1070 BRUSSELS,BELGIUM
[2] FREE UNIV BRUSSELS,HOP ERASME,PLURIDISCIPLINAIRE RECH EXPTL BIOMED LAB,B-1070 BRUSSELS,BELGIUM
关键词
INTERFERON-GAMMA; INTERLEUKIN-2; INTERLEUKIN-10; STAPHYLOCOCCAL ENTEROTOXIN B; SUPERANTIGEN;
D O I
10.1002/eji.1830250503
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The superantigen staphylococcal enterotoxin B (SEB) induces a defect in interleukin (IL)-2 production by T celIs expressing specific T cell receptor V beta domains. The present study was undertaken to determine the capacity of T cells, made deficient in IL-2 production by exposure to SEB in vivo, to secrete interferon (IFN)-gamma and IL-10 and to induce pathology upon SEB rechallenge. For this purpose, BALB/c mice received two intraperitoneal injections of 100 mu g SEB with a 48-h interval. First, we compared peak serum levels of IL-2, IFN-gamma and IL-10 after SEB rechallenge with those measured after a single SEB injection in control mice. The expected defect in IL-2 production in SEB-pretreated mice was associated with a major increase in IL-10 and IFN-gamma levels which were about fivefold higher than in controls. Experiments in mice depleted of CD4(+) or CD8(+) cells as well as studies in which purified T cell populations were rechallenged with SEE in vitro indicated that both CD4(+) and CD8(+) cells from SEB-pretreated mice were primed for IL-10 and IFN-gamma production. Furthermore, SEB-pretreated mice were sensitized to the toxic effects of the superantigen as indicated by a 30-70% lethality rate (vs. 0% in naive mice) within 48 h after SEB rechallenge. IFN-gamma was involved in the lethal syndrome as it could be prevented by injection of neutralizing anti-IFN-gamma monoclonal antibody. We conclude that SEB-reactive T cells made deficient for the production of IL-2 by exposure to SEB in vivo are primed for IFN-gamma and IL-10 production, and that IFN-gamma up-regulation is involved in the shock syndrome occurring upon SEE rechallenge.
引用
收藏
页码:1148 / 1153
页数:6
相关论文
共 33 条
[1]   AGE-DEPENDENT CHANGES IN THE RESPONSE TO STAPHYLOCOCCAL-ENTEROTOXIN-B [J].
AROEIRA, LS ;
WILLIAMS, O ;
LOZANO, EG ;
MARTINEZ, C .
INTERNATIONAL IMMUNOLOGY, 1994, 6 (10) :1555-1560
[2]  
Ausubel F. M., 1993, CURRENT PROTOCOLS MO
[3]   CLONAL ANERGY TO STAPHYLOCOCCAL ENTEROTOXIN-B IN-VIVO - SELECTIVE EFFECTS ON T-CELL SUBSETS AND LYMPHOKINES [J].
BASCHIERI, S ;
LEES, RK ;
LUSSOW, AR ;
MACDONALD, HR .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (10) :2661-2666
[4]   INTERLEUKIN-10 PROTECTS MICE AGAINST STAPHYLOCOCCAL-ENTEROTOXIN B-INDUCED LETHAL SHOCK [J].
BEAN, AGD ;
FREIBERG, RA ;
ANDRADE, S ;
MENON, S ;
ZLOTNIK, A .
INFECTION AND IMMUNITY, 1993, 61 (11) :4937-4939
[5]   INVIVO ROLE OF INTERLEUKIN-4 IN T-CELL TOLERANCE INDUCED BY AQUEOUS PROTEIN ANTIGEN [J].
BURSTEIN, HJ ;
ABBAS, AK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :457-463
[6]   EXPRESSION OF INTERLEUKIN-2 RECEPTORS AS A DIFFERENTIATION MARKER ON INTRATHYMIC STEM-CELLS [J].
CEREDIG, R ;
LOWENTHAL, JW ;
NABHOLZ, M ;
MACDONALD, HR .
NATURE, 1985, 314 (6006) :98-100
[7]  
COLIGAM J, 1992, CURRENT PROTOCOLS IM
[8]   CHARACTERIZATION OF THE MURINE ANTIGENIC DETERMINANT, DESIGNATED L3T4A, RECOGNIZED BY MONOCLONAL-ANTIBODY GK1.5 - EXPRESSION OF L3T4A BY FUNCTIONAL T-CELL CLONES APPEARS TO CORRELATE PRIMARILY WITH CLASS II MHC ANTIGEN-REACTIVITY [J].
DIALYNAS, DP ;
WILDE, DB ;
MARRACK, P ;
PIERRES, A ;
WALL, KA ;
HAVRAN, W ;
OTTEN, G ;
LOKEN, MR ;
PIERRES, M ;
KAPPLER, J ;
FITCH, FW .
IMMUNOLOGICAL REVIEWS, 1983, 74 :29-56
[9]   INVIVO INDUCTION OF INTERLEUKIN-10 BY ANTI-CD3 MONOCLONAL-ANTIBODY OR BACTERIAL LIPOPOLYSACCHARIDE - DIFFERENTIAL MODULATION BY CYCLOSPORINE-A [J].
DUREZ, P ;
ABRAMOWICZ, D ;
GERARD, C ;
VANMECHELEN, M ;
AMRAOUI, Z ;
DUBOIS, C ;
LEO, O ;
VELU, T ;
GOLDMAN, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :551-555
[10]  
FLORQUIN S, 1994, J IMMUNOL, V153, P2618